Xianhui Qin Selected Research

Enalapril

11/2022	Plasma selenium and the risk of first stroke in adults with hypertension: a secondary analysis of the China Stroke Primary Prevention Trial.
1/2022	Joint Association of Low Vitamin K1 and D Status With First Stroke in General Hypertensive Adults: Results From the China Stroke Primary Prevention Trial (CSPPT).
10/2021	Interaction of neutrophil counts and folic acid treatment on new-onset proteinuria in hypertensive patients.
1/2021	Plasma Vitamin E and the Risk of First Stroke in Hypertensive Patients: A Nested Case-Control Study.
1/2021	Interaction of Serum Alkaline Phosphatase and Folic Acid Treatment on Chronic Kidney Disease Progression in Treated Hypertensive Adults.
1/2021	Interaction of serum calcium and folic acid treatment on first stroke in hypertensive males.
1/2020	PNPT1 and PCGF3 variants associated with angiotensin-converting enzyme inhibitor-induced cough: a nested case-control genome-wide study.
1/2020	Interaction of serum vitamin B12 and folate with MTHFR genotypes on risk of ischemic stroke.
1/2020	Estimated Stroke-Free Survival of Folic Acid Therapy for Hypertensive Adults: Projection Based on the CSPPT.
1/2018	Effect of Smoking and Folate Levels on the Efficacy of Folic Acid Therapy in Prevention of Stroke in Hypertensive Men.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xianhui Qin Research Topics

Disease

51	Stroke (Strokes) 11/2022 - 06/2007
43	Hypertension (High Blood Pressure) 11/2022 - 07/2009
16	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 06/2007
13	Ischemic Stroke 07/2022 - 04/2015
13	Chronic Renal Insufficiency 01/2022 - 03/2011
8	Proteinuria 11/2021 - 12/2015
7	Neoplasms (Cancer) 01/2020 - 09/2013
6	Hemorrhagic Stroke 01/2020 - 01/2019
5	Diabetes Mellitus 10/2020 - 01/2017
4	Obesity 03/2022 - 01/2012
4	Abdominal Obesity 03/2022 - 01/2012
4	Myocardial Infarction 01/2018 - 03/2016
3	Chronic Kidney Failure (Chronic Renal Failure) 01/2022 - 03/2011
3	Atherosclerosis 11/2020 - 06/2012
3	Essential Hypertension 01/2018 - 01/2012
2	Albuminuria 06/2022 - 01/2022
2	Hypertensive Retinopathy 10/2020 - 06/2017
2	Kidney Diseases (Kidney Disease) 01/2020 - 10/2013
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2019 - 09/2013
2	Hyperuricemia 01/2019 - 01/2017
2	Dyslipidemias (Dyslipidemia) 01/2017 - 11/2015
2	Hypercholesterolemia 11/2016 - 04/2015
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 11/2022
1	Inflammation (Inflammations) 06/2022
1	Frailty 06/2022
1	Type 2 Diabetes Mellitus (MODY) 03/2022
1	Vascular Calcification 01/2022
1	Liver Diseases (Liver Disease) 01/2021
1	Cough 01/2020
1	Renal Insufficiency (Renal Failure) 01/2020
1	Appendicitis 07/2019
1	Esophageal Neoplasms (Esophageal Cancer) 01/2019
1	Digestive System Neoplasms (Cancer of the Digestive System) 01/2019

Drug/Important Bio-Agent (IBA)

42	Folic Acid (Vitamin M)FDA LinkGeneric 11/2022 - 06/2007
27	Enalapril FDA LinkGeneric 11/2022 - 01/2012
19	HomocysteineIBA 01/2022 - 06/2007
12	Antihypertensive Agents (Antihypertensives)IBA 11/2022 - 01/2012
9	Uric Acid (Urate)IBA 11/2020 - 01/2017
7	Glucose (Dextrose)FDA LinkGeneric 03/2022 - 01/2017
6	CreatinineIBA 06/2022 - 03/2011
6	TabletsIBA 01/2017 - 01/2012
5	hydroxide ionIBA 11/2022 - 10/2019
5	Blood Glucose (Blood Sugar)IBA 11/2022 - 01/2017
5	CholesterolIBA 10/2020 - 11/2016
5	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 10/2020 - 11/2015
5	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 01/2020 - 02/2015
4	SeleniumIBA 11/2022 - 01/2019
4	AlbuminsIBA 06/2022 - 12/2015
4	CopperIBA 01/2022 - 01/2019
4	ORALIT (ORS)IBA 01/2022 - 04/2015
4	Vitamin A (Retinol)FDA LinkGeneric 01/2021 - 01/2019
3	ManganeseIBA 05/2022 - 01/2022
3	Triglycerides (Triacylglycerol)IBA 03/2022 - 07/2019
3	oxidized low density lipoproteinIBA 11/2020 - 01/2017
3	LipidsIBA 07/2019 - 09/2013
2	25-hydroxyvitamin DIBA 11/2022 - 10/2019
2	Vitamin D FDA LinkGeneric 11/2022 - 01/2022
2	Carnitine (L-Carnitine)FDA LinkGeneric 10/2022 - 01/2018
2	Calcifediol (Calcidiol)FDA Link 07/2022 - 11/2021
2	HDL CholesterolIBA 03/2022 - 08/2015
2	Vitamin K 1 (Phylloquinone)FDA LinkGeneric 01/2022 - 01/2022
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2022 - 01/2020
2	Cystatin CIBA 01/2022 - 09/2021
2	Trace Elements (Biometals)IBA 01/2022 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2020
2	ZincIBA 07/2021 - 11/2019
2	Alkaline PhosphataseIBA 01/2021 - 01/2021
2	Vitamin E FDA LinkGeneric 01/2021 - 01/2019
2	BilirubinIBA 01/2020 - 01/2018
2	Indicators and Reagents (Reagents)IBA 11/2017 - 12/2014
1	C-Reactive ProteinIBA 06/2022
1	Pantothenic Acid (Calcium Pantothenate)FDA Link 01/2022
1	Vitamin K FDA Link 01/2022
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2022
1	5,11-methenyltetrahydrohomofolateIBA 01/2022
1	Dietary ProteinsIBA 01/2022
1	Selenoproteins (Selenoprotein)IBA 01/2022
1	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2022
1	Neprilysin (Neutral Endopeptidase)IBA 01/2022
1	Syntex adjuvant formulationIBA 01/2021
1	CalciumIBA 01/2021
1	Dietary Carbohydrates (Carbohydrate, Dietary)IBA 01/2021
1	Niacin (Nicotinic Acid)FDA LinkGeneric 01/2021
1	Riboflavin (Vitamin B2)FDA LinkGeneric 12/2020
1	Dietary SodiumIBA 12/2020
1	PotassiumIBA 12/2020
1	VitaminsIBA 10/2020
1	Serum AlbuminIBA 01/2020
1	MagnesiumIBA 01/2020
1	Betaine (C.B.B.)FDA Link 01/2020
1	BradykininIBA 01/2020
1	SaltsIBA 01/2020
1	AldosteroneIBA 12/2019
1	ReninIBA 12/2019
1	ProcalcitoninIBA 07/2019
1	LDL CholesterolIBA 07/2019
1	Phosphates (Orthophosphate)IBA 01/2019

Therapy/Procedure

14	Therapeutics 01/2020 - 07/2009
6	Duration of Therapy 11/2017 - 06/2007
2	Peritoneal Dialysis 01/2022 - 01/2022